Related references
Note: Only part of the references are listed.Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes
Jeanne Guitton et al.
CELLS (2020)
Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology
E. Jozefczuk et al.
PHARMACOLOGICAL RESEARCH (2020)
Sphingosine 1-phosphate signaling in ischemia and reperfusion injury
Zohaib Raza et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2020)
A G protein-biased S1P1 agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers
Bruno Poirier et al.
SCIENCE SIGNALING (2020)
A label-free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P1 agonists
Patrick Grailhe et al.
FEBS OPEN BIO (2020)
Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events JACC Review Topic of the Week
Jane Armitage et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Andreane Cartier et al.
SCIENCE (2019)
Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
Elena M. G. Diarte-Anazco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Sphingosine-1-phosphate signaling in blood pressure regulation
Suttira Intapad
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Loss of sphingosine 1-phosphate (S1P) in septic shock is predominantly caused by decreased levels of high-density lipoproteins (HDL)
Martin Sebastian Winkler et al.
JOURNAL OF INTENSIVE CARE (2019)
Sphingosine 1-Phosphate and Atherosclerosis
Makoto Kurano et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Type 2 diabetes is associated with loss of HDL endothelium protective functions
Tomas Vaisar et al.
PLOS ONE (2018)
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options JACC State-of-the-Art Review
Viviany R. Taqueti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
Mario Ruiz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
The role of sphingolipid signalling in diabetes-associated pathologies
Mei Li Ng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex
Cecilia Frej et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS Correction by S1P Enrichment
Damien Denimal et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S. Rosenson et al.
NATURE REVIEWS CARDIOLOGY (2016)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
Christopher Southan et al.
NUCLEIC ACIDS RESEARCH (2016)
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection
Jonas W. Brinck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model
Nageh Ahmed El-Mahdy et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Sphingosine-1-Phosphate Signaling in Endothelial Disorders
Teresa Sanchez
CURRENT ATHEROSCLEROSIS REPORTS (2016)
Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1
Pernille M. Christensen et al.
FASEB JOURNAL (2016)
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis
Sina M. Coldewey et al.
SCIENTIFIC REPORTS (2016)
Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans
Irina Soltau et al.
PLOS ONE (2016)
S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis
Anna Cantalupo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis
Xiao-Dong Jing et al.
CLINICA CHIMICA ACTA (2015)
Long-term phosphodiesterase 5 inhibitor administration reduces inflammatory markers and heat-shock proteins in cavernous tissue of Zucker diabetic fatty rat (ZDF/fa/fa)
J. E. Toblli et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2015)
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content Correction by Sphingosine-1-Phosphate-Loading
Katherine Sattler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Sphingosine-1-phosphate receptor 1 transmits estrogens' effects in endothelial cells
Olga Sukocheva et al.
STEROIDS (2015)
Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis
Yasushi Matsuzawa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen
Shoudong Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)
Francesco Poti et al.
CARDIOVASCULAR RESEARCH (2014)
Sphingosine 1-Phosphate in Blood: Function, Metabolism, and Fate
Andreas V. Thuy et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects
M. Hoch et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes The Hoorn Study
Thomas T. van Sloten et al.
HYPERTENSION (2014)
Angiotensin II Receptor Blockers Improve Peripheral Endothelial Function: A Meta-Analysis of Randomized Controlled Trials
Shuang Li et al.
PLOS ONE (2014)
Meta-Analysis of Clinical Dose-Response in a Large Drug Development Portfolio
Neal Thomas et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2014)
The Vascular Endothelium and Human Diseases
Peramaiyan Rajendran et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute Myocardial infarction
Malgorzata Knapp et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus
Lin Zhang et al.
ATHEROSCLEROSIS (2012)
Torcetrapib impairs endothelial function in hypertension
Branko Simic et al.
EUROPEAN HEART JOURNAL (2012)
Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
Thomas F. Luescher et al.
EUROPEAN HEART JOURNAL (2012)
Daily Use of Sildenafil Improves Endothelial Function in Men With Type 2 Diabetes
Ling Deyoung et al.
JOURNAL OF ANDROLOGY (2012)
Obstructive Coronary Atherosclerosis and Ischemic Heart Disease: An Elusive Link!
Mario Marzilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Fingolimod-associated macular edema Incidence, detection, and management
Nieraj Jain et al.
NEUROLOGY (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: A meta-analysis of randomised controlled trials
Yousef Shahin et al.
ATHEROSCLEROSIS (2011)
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats
Yoshihiro Kuno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
Kelley M. Argraves et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
Katherine J. E. Sattler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events
Ronen Rubinshtein et al.
EUROPEAN HEART JOURNAL (2010)
Assessment of atherosclerosis: the role of flow-mediated dilatation
Marietta Charakida et al.
EUROPEAN HEART JOURNAL (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats
Kyung-Hwan Jeong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Sphingosine-1-phosphate and modulation of vascular tone
Junsuke Igarashi et al.
CARDIOVASCULAR RESEARCH (2009)
Endothelial Function Predicts Progression of Carotid Intima-Media Thickness
Julian P. J. Halcox et al.
CIRCULATION (2009)
Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients
Alin Stirban et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes
A. Aversa et al.
DIABETIC MEDICINE (2008)
High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function
Kelley M. Argraves et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients - A double-masked, randomized, controlled trial
Jan Balzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients
Timm H. Westhoff et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT
Claudio Ceconi et al.
CARDIOVASCULAR RESEARCH (2007)
FTY720 versus MMF with cyclosporine in de novo renal transplantation:: A 1-year, randomized controlled trial in Europe and Australasia
M. Salvadori et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk
GMC Rosanoa et al.
EUROPEAN UROLOGY (2005)
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia
JPJ Halcox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes
C Desouza et al.
DIABETES CARE (2002)
Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
F Okajima
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients
S Taddei et al.
JOURNAL OF HYPERTENSION (2001)
Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state
GJ Etgen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Share Paper
